Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

Jiangsu Yahong Meditech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	313.14	779.45	628.2	1,738	1,035	2,613
Short-Term Investments	-	161.24	150.54	14.54	-	-
Trading Asset Securities	843.05	668	657.21	594.31	1,703	369.77
Cash & Short-Term Investments	1,156	1,609	1,436	2,347	2,738	2,983
Cash Growth	-31.42%	12.03%	-38.82%	-14.29%	-8.20%	273.49%
Accounts Receivable	119.75	98.56	59.9	8.68	0.02	0
Other Receivables	6.44	6.46	11.63	5.9	3.04	2.07
Receivables	126.19	105.02	71.53	14.57	3.06	2.08
Inventory	28.51	21.92	5.84	1.61	2.79	3.81
Other Current Assets	218.27	26.12	17.63	12.2	15.93	19.79
Total Current Assets	1,529	1,762	1,531	2,375	2,760	3,009
Property, Plant & Equipment	56.24	73.49	85.45	88.5	36.8	26.88
Long-Term Investments	51.1	99.85	474.22	26.41	15.34	-
Other Intangible Assets	104.05	73.68	53.98	61.39	21.79	22.13
Long-Term Deferred Tax Assets	2.55	2.4	2.09	1.26	0.25	-
Long-Term Deferred Charges	4.62	4.5	5.96	9.86	12.13	7.79
Other Long-Term Assets	45.35	41.83	70.35	69.4	27.64	33.43
Total Assets	1,793	2,057	2,223	2,632	2,874	3,099

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	35.93	51.54	47.26	59.22	43.65	33.57
Accrued Expenses	32.99	80.56	55.32	38.42	24.64	32.92
Short-Term Debt	63.44	238.5	66.25	73.4	-	-
Current Portion of Long-Term Debt	48.1	1.3	-	-	-	-
Current Portion of Leases	-	17.91	14.34	10.29	7.37	5.66
Current Income Taxes Payable	7.17	-	0.31	0.34	1.52	-
Current Unearned Revenue	1.08	0.22	0.31	-	-	-
Other Current Liabilities	61.64	12.36	13.28	3.67	3.48	1.74
Total Current Liabilities	250.35	402.4	197.06	185.35	80.66	73.89
Long-Term Debt	253.56	48.44	-	-	-	-
Long-Term Leases	27.65	39	49.95	50.77	11.31	11.76
Long-Term Unearned Revenue	4.08	4.6	5.61	6.39	11	0.32
Long-Term Deferred Tax Liabilities	0.01	-	-	-	0	-
Other Long-Term Liabilities	50	-	-	-	-	-
Total Liabilities	585.65	494.44	252.62	242.5	102.98	85.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	572.19	571.17	570	570	570	570
Additional Paid-In Capital	2,909	2,907	2,884	2,863	2,848	2,841
Retained Earnings	-2,207	-1,845	-1,429	-1,045	-644.27	-397.92
Treasury Stock	-35.31	-50.06	-50.06	-	-	-
Comprehensive Income & Other	-7.81	-6.74	-5.54	-0.38	-2.44	-
Total Common Equity	1,231	1,576	1,969	2,388	2,771	3,013
Minority Interest	-23.73	-13.28	0.97	1.8	-	-
Shareholders' Equity	1,207	1,563	1,970	2,390	2,771	3,013
Total Liabilities & Equity	1,793	2,057	2,223	2,632	2,874	3,099

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	392.75	345.15	130.54	134.46	18.69	17.42
Net Cash (Debt)	763.44	1,264	1,305	2,213	2,720	2,966
Net Cash Growth	-44.22%	-3.21%	-41.00%	-18.64%	-8.29%	271.31%
Net Cash Per Share	1.36	2.25	2.31	3.70	4.74	6.44
Filing Date Shares Outstanding	559.46	562.5	561.33	570	570	570
Total Common Shares Outstanding	559.46	562.5	561.33	570	570	570
Working Capital	1,279	1,359	1,334	2,190	2,679	2,935
Book Value Per Share	2.20	2.80	3.51	4.19	4.86	5.29
Tangible Book Value	1,127	1,503	1,915	2,327	2,749	2,991
Tangible Book Value Per Share	2.01	2.67	3.41	4.08	4.82	5.25
Machinery	-	52.29	49.56	46.55	27.8	15.67

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error